NCT02193633View on ClinicalTrials.gov

A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel.

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 26, 2013

Primary Completion Date

November 15, 2017

Study Completion Date

November 15, 2017

Conditions
Advanced Cancer
Interventions
DRUG

AZD2014 3 on/4 off & weekly paclitaxel

AZD2014 3 days on, 4 days off + weekly paclitaxel

DRUG

AZD2014 2 on/5 off & weekly paclitaxel

AZD2014 2 days on, 5 Days off + weekly paclitaxel

Trial Locations (4)

CB2 0QQ

Addenbrookes Hospital, Cambridge

SM2 5PT

Royal Marsden Hospital, Sutton

BT9 7AB

Belfast City Hospital, Belfast

SE1 9RT

Guy's and St Thomas's NHS Foundation Trust, London

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

Institute of Cancer Research, United Kingdom

OTHER

collaborator

AstraZeneca

INDUSTRY

lead

Royal Marsden NHS Foundation Trust

OTHER